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Summary
The clinical features of the 9p-deletion syndrome include
dysmorphic facial features (trigonocephaly, midface hy-
poplasia, upward-slanting palpebral fissures, and a long
philtrum) and mental retardation. The majority of these
patients appear to have similar cytogenetic breakpoints
in 9p22, but some cases show phenotypic heterogeneity.
To define the breakpoints of the deleted chromosomes,
we studied 24 patients with a deletion of 9p, by high-
resolution cytogenetics, FISH with 19 YACs, and PCR
using 25 different sequence-tagged sites. Of 10 different
breakpoints identified, 9 were localized within an ∼5-
Mb region, in 9p22-p23, that encompasses the interval
between D9S1869 (telomeric) and D9S162 (centromer-
ic). Eight unrelated patients had a breakpoint (group 1)
in the same interval, between D9S274 (948h1) and
D9S285 (767f2), suggesting a chromosome-breakage
hotspot. Among 12 patients, seven different breakpoints
(groups 3–9) were localized to a 2-Mb genomic region
between D9S1709 and D9S162, which identified a
breakpoint-cluster region. The critical region for the 9p-
deletion syndrome maps to a 4–6-Mb region in 9p22-
p23. The results from this study have provided insight
into both the heterogeneous nature of the breakage in
this deletion syndrome and the resultant phenotype-kar-
yotype correlations.
Introduction
The chromosome-9p deletion was initially characterized
in 1973 by Alfi et al., who reported a characteristic phe-
notype observed in six patients (Alfi et al. 1973) (mono-
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somy 9p syndrome [MIM 158170]). The major clini-
cal features in this syndrome include mental retardation,
trigonocephaly, midface hypoplasia, upward-slanting
palpebral fissures, and a long philtrum (Young et al.
1982; Huret et al. 1988). Trigonocephaly and upward-
slanting palpebral fissures are found in virtually all pa-
tients with this syndrome. In 1100 patients, features fre-
quently seen in this condition include hypertelorism, ep-
icanthus, small palpebral fissures, flat nasal bridge,
anteverted nares, low-set malformed posteriorly angu-
lated ears, microstomia, micrognathia, short-appearing
neck, widely spaced nipples, square hyperconvex nails,
dolichomesophalangy, and hypotonia. Less frequently,
other malformations have been seen, which include car-
diac defects, hernias, omphaloceles, choanal atresia, ab-
normal genitalia, and scoliosis (Breg et al. 1976; Huret
et al. 1988; Taylor et al. 1991; Bennett et al. 1993; Teebi
et al. 1993; Shashi et al. 1994). Nonketotic hypergly-
cemia has been recognized in a small number of patients
(Burton et al. 1989).
In a review of 80 literature cases with deletions of 9p,
Huret et al. (1988) found that approximately half were
due to de novo deletions and that the remaining half
were due to unbalanced rearrangements. The majority
(39/41) of the unbalanced rearrangements were familial.
Cytogenetics studies have suggested that breaks can oc-
cur in 9p21-p23. To date, two studies have used addi-
tional molecular techniques to characterize a small num-
ber of cases (Teebi et al. 1993; Wagstaff and Hemann
1995). Teebi et al. (1993) characterized two rearranged
chromosomes 9 by using chromosome-specific libraries.
Wagstaff and Hemann (1995), utilizing microsatellite
markers, characterized two deletions and initially re-
ported the 9p deletion–syndrome critical region as in-
cluding the interval between D9S286 and D9S162.
The lack of high-resolution chromosome analysis and
molecular analysis can lead to both misassignment of
the breakpoint and failure to detect additional chro-
mosomal material or a derived chromosome 9 and can
obscure phenotype/karyotype correlations. To define the
breakpoints in all of the rearrangements in a large group
of patients, we first determined whether these are de-
letions or cryptic unbalanced rearrangements and, sec-
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Table 1
Patient Population, Cytogenetic Abnormality, and Origin of
Rearrangement
Patient Rearrangement (Type)
Parental
Origin
Group 1:
1a Deletion (de novo) Paternal
2a Deletion (de novo) Paternal
3 Unbalanced translocationb (familial) Maternal
4a Deletion (de novo) Paternal
5 Deletion (de novo) Unknown
6 Unbalanced translocationc (de
novo)
Maternal
7d Deletion (unknown) Unknown
8 Deletion (de novo) Maternal
Group 1/2:
9a Deletion (de novo) Paternal
Group 2:
10a Deletion (de novo) Paternal
Group 3:
11e Deletion (unknown) Unknown
12a Deletion (de novo) Maternal
Group 4:
13 Unbalanced translocationf (familial) Maternal
Group 5:
14 Deletion (de novo) Paternal
Group 6:
15a Deletion (de novo) Paternal
16a Inversion/deletiong (de novo) Paternal
17a Deletion (de novo) Maternal
Group 7:
18h Deletion (unknown) Unknown
Group 8:
19a Deletion (de novo) Maternal
20a Deletion (de novo) Maternal
Group 8/9:
21 Duplication/deletioni (de novo) Maternal
Group 9:
22a Deletion (de novo) Maternal
Group 10:
23a Deletion (de novo) Paternal
24j Deletion (de novo) Unknown
a Reported by Micale et al. (1995).
b 46,XX,der(9)t(3;9)(p26.2;p22.3)mat.
c 46,XX,der(9)t(7;9)(p21.3;p22.1).
d GM10094.
e GM01667.
f 46,XY,der(9)t(3;9)(p24.2;p22.1)mat.
g 46,XX,del(9)(:q12rp22.3::q12rqter).
h GM2356.
i mos46,XX,del(9)(p22.1)/46,XX,der(9)t(9;9)(:p11rp22.1::
p22.1rqter).
j GM00870.
ond, established molecular breakpoints to determine the
pattern and mechanism of breakage in these patients.
Patients and Methods
Clinical Population
A total of 24 patients with deletions or rearrangements
in the short arm of chromosome 9 were ascertained for
this study (table 1). Four of these samples (GM10994,
GM01667, GM02356, and GM00870) were obtained
from the National Institute of General Medical Sciences’
Genetic Mutant Cell Repository. The other 20 samples
were obtained directly from patients either seen at Case
Western Reserve University and involved with the
Chromosome 9p Network or referred from other lab-
oratories. All of these patients were reported to have
trigonocephaly and features compatible with the 9p-de-
letion syndrome. The patient records for these latter 20
patients were reviewed by one of the authors (C.A.C.),
to identify those clinical features of the 9p-deletion syn-
drome. Photographs were reviewed when patients were
not available for physical examination.
Cytogenetic Studies
Metaphase chromosomes were prepared either from
phytohemagglutinin (PHA)-stimulated cultures or from
lymphoblast or fibroblast cultures, by standard proce-
dures. Leukocytes from peripheral blood of the pro-
bands were cultured to obtain chromosomes at
600–750-band level (Yunis 1976; Ikeuchi 1984).
PHA-stimulated blood leukocytes were cultured for ∼72
h in RPMI 1640 with 17% fetal bovine serum. The
cultures were synchronized by the addition of thymidine
for the last 16.5 h of culture, followed by the addition
of ethidium bromide and colcemid for the last 45 min
and 25min of culture, respectively. The cells were treated
for 8 min with 0.075 M KCl and were fixed in 3:1
methanol–acetic acid prior to staining. The chromo-
somes were GTG-banded, and 20 chromosomal
spreads were examined (Seabright 1971).
FISH Studies
FISH was performed with YACs and chromosome-
specific paints on the unstained slides, according to the
technique of Pinkel et al. (1986, 1988), with minor mod-
ifications (Sullivan et al. 1996). At least 10—and, inmost
cases, 20—metaphases were analyzed for the presence
of probe on both the normal and the rearranged chro-
mosome. All of the YACs utilized in this study were
obtained from Research Genetics, after examination of
the Whitehead Institute for Biomedical Research/MIT
Center for Genome Research database. All of the YACs
used in this study were mapped on the basis of sequence-
tagged site (STS) content (fig. 1 and table 2).
Digital images were captured by a confocal micro-
scope and/or Zeiss epifluorescent microscope equipped
with a cooled CCD camera (Photometrics CG250) con-
trolled by an Apple MacIntosh computer. Gray-scale
source images were captured separately with DAPI, pro-
pidium iodide fluorescein, and rhodamine filter sets and
were merged and pseudocolored by Gene Join software
(Yale University).
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Table 2
Delineation of Breakpoint Groups
GROUP
STATUS OF YAC/STS
Deleted Present
1 948h1 767f2
2 D9S285 V767f2 (reduced signal)
3 D9S156 742e6
4 718el 769h3
5 D9S157 877g2
6 769h3 791h3
7 791h3 776c5
8 776c5 950g5
9 950g5 924e7
10 924e7 778h8
Figure 1 YAC/STS map and 10 different breaks in 9p22-9p23 in the 24 patients studied. The STSs in our area of interest are ordered
telomeric (TEL) to centromeric (CEN) on a horizontal axis, and several YACs localized to this region are placed above. The STSs contained
in each YAC are indicated by circles. All of the STSs associated with the YACs used in the present study are listed; however, only a portion of
these were used for breakpoint analysis and determination of parental origin (D9S268, D9S274, D9S285, D9S156, D9S157, D9S925, and
D9S162). Only the YACs that were instrumental in the delineation of the groups (767f2, 948h1, 937c8, 742e6, 877g12, 769h3, 791h3, 950g5,
and 924e7) are listed. Each patient is denoted by a line, indicating nondeleted material from chromosome 9p. Those patients studied by both
YAC and microsatellite-marker analysis are denoted by a solid line, whereas patients studied only with YACs are denoted by a dashed line.
The delineation of the various groups is shown in table 2. Patients 9 and 21 could not be precisely defined and were each placed within two
groups (table 1).
Molecular Studies
Highly polymorphic microsatellite markers within or
adjacent to the deleted region for each patient—and for
their parents, when DNA from the latter was available
(table 1)—were analyzed by PCR, by means of standard
techniques. Primer sequences for microsatellite analysis
(Operon Technologies or Research Genetics) were ob-
tained from the Whitehead Institute for Biomedical Re-
search/MIT Center for Genome Research and The Ge-
nome Database and were used with standard methods
(Micale et al. 1995). Molecular distances in this study
were estimated by radiation hybrid data from theWhite-
head Institute for Biomedical Research/MIT Center for
Genome Research.
Results
Initially, chromosome analyses of leukocytes at the
600–750-band level were performed; if the banding was
suggestive of a rearrangement (e.g., in 3 of the 22 de
novo cases), chromosome-specific paints were used to
determine the origin of the extra material. Of the 24
cases examined in this study (table 1), 2 (cases 3 and
13) had a derived chromosome 9 due to malsegregation
of a familial translocation. Of the other 22 cases studied,
19 appeared to be simple deletions; the remaining 3
cases involved more-complex rearrangements—a de
novo duplication of 7p along with a 9p deletion, der(9)
t(7;9)(p21.3;p22.1), in case 6; an inversion with a con-
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Figure 2 FISH delineating the three structural abnormalities detected in this study. A, Chromosome 7 library, showing der(9)t(7;9) (case
6). B, Chromosome 9 classic satellite probe, showing the presence of an inversion in the inversion/deletion case (case 16). C, YAC 929d12,
showing the duplication/deletion (case 21). Arrows indicate the derived chromosomes.
comitant deletion, del(9)(:q12rp22.3::q12rqter), in
case 16; and a mosaic intrachromosomal duplication
and deletion of chromosome 9, mos46,XX,del(9)(p22.1)
/46,XX,der(9)t(9;9)(:p11rp22.1::p22.1rqter), in case
21 (fig. 2). Chromosome analysis revealed that the
breakpoints of the 24 patients were indistinguishable
and within 9p22-p23. This finding suggested a need for
more-detailed molecular cytogenetic studies involving
both FISH with YACs and PCR analysis with micro-
satellite markers (figs. 1 and 3).
The results of our FISH analysis with YACs and mi-
crosatellite analysis indicate that various proximal
breakpoints are involved in the deletions. At least 10
different molecular breakpoints (groups 1–10) were de-
Figure 3 Four examples of FISH with different YACs. A, Group 1 patient (case 8) with a deletion of YAC 948h1. The arrowhead indicates
hybridization on the normal chromosome 9, and the arrow indicates lack of hybridization of the deleted chromosome 9.B,Group 6 translocation-
carrier parent (case 3) with a split signal of YAC 937c8. The arrowhead indicates hybridization on the normal chromosome 9, and the arrow
indicates hybridization on both the der(3) and the der(9). C, Group 2 patient (case 10) with a reduced signal from hybridization with YAC
767f2. The arrowhead indicates hybridization on the normal chromosome 9, and the arrow indicates a reduced signal on the deleted chromosome
9. D, Group 8 patient (case 20) with a reduced signal from hybridization YAC 950g5. The arrowhead indicates hybridization on the normal
chromosome 9, and the arrow indicates a reduced signal on the deleted chromosome 9.
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tected among the 24 patients (table 1 and fig. 1). Nine
different breakpoints (groups 1–9) have been localized
to an ∼5-Mb region in 9p22-p23, between D9S274 and
D9S162 (fig. 1). All of these breakpoints were localized
either within a YAC or between two STSs. Figure 1
illustrates the breakpoints identified in groups 1 and 2,
between D9S274 and D9S285. PCR with microsatellite
markers revealed that D9S274 was deleted in both
groups, whereas D9S285 was present only in patient 10
(group 2), and FISH analysis demonstrated that se-
quences in YACs 948h1 and 924b12 were deleted in
these patients, whereas those sequences were present
in YAC 767f2. The patient in group 2 (patient 10)
showed a reduced signal when hybridized with YAC
767f2 (fig. 3).
Eight of the 24 patients were determined to have the
group 1 breakpoint, the largest number of patients as-
signed to any groups. Seven of the breakpoints (groups
3–9), encompassing 12 patients, were localized to just
a 2-Mb region in 9p22 (fig. 1). All of these breaks were
clustered between D9S1972 and D9S162, and the close
proximity and number of breaks suggested a possible
breakpoint-cluster region.
Parental Origin of the Deletion
Our initial studies delineating parental origin were
performed in 13 families with de novo 9p deletions/
rearrangements, by use of 9p dinucleotide-repeat micro-
satellite markers (Micale et al. 1995); we have now ob-
tained an additional 4 families. Combined results from
the 17 families have revealed that the 9p deletion is of
paternal origin in 9 of them and is of maternal origin
in 8 families.
Chromosome 9p Deletion: Critical Region
To better delineate a critical region for the 9p-deletion
phenotype, we have correlated the above molecular find-
ings with the phenotypic findings available for these pa-
tients. Records have been obtained on the available pa-
tients, although only a few have been studied clinically
at Case Western Reserve University. Nonetheless, pre-
liminary phenotype/karyotype correlation can be made
on the basis of this information.
All of the patients with breaks in groups 1–10 show
a characteristic phenotype compatible with the 9p-de-
letion syndrome. These features include trigonocephaly,
flat occiput, small palpebral fissures, flat nasal bridge,
anteverted nostrils, long philtrum, and microretrogna-
thia. Recently, Wagstaff and Hemann’s (1995) report of
a patient with a 15-Mb interstitial deletion (from
D9S286 to D9S162) helped to initially delineate this
critical region. On the basis of our studies, we have
reduced the size of the apparent critical region and can
assign it to an ∼4–6-Mb region in 9p23—a region en-
compassing the interval between D9S286 and D9S285,
the smallest region of overlap between our patients and
the patient reported by Wagstaff and Hemann (1995).
Discussion
The chromosome 9–deletion syndrome is a fairly well-
established and -recognized deletion syndrome (Huret et
al. 1988). In this study we have examined 24 deletions
or rearrangements of 9p, to delineate more precisely the
nature of the abnormal chromosome and to determine
the molecular breakpoints, using both FISH with single-
copy probes and PCR with microsatellite markers.
Initial Cytogenetic Analysis
The majority of the cases obtained for this study had
been diagnosed and analyzed previously. For consis-
tency, each case, when possible, was restudied by high-
resolution banding. Any detection of a banding pattern
not consistent with a deletion was followed by use of a
chromosome 9 library and subsequent use of other chro-
mosome libraries, to detect the chromosomal origin of
any non–chromosome 9 material. Three of the 22 de
novo abnormalities were subjected to additional studies.
These chromosomal and FISH studies not only detected
2 familial translocations and 19 de novo deletions but,
in addition, also delineated 3 unusual de novo rear-
rangements (1 translocation, 1 inversion and deletion,
and 1 intrachromosomal duplication and deletion). This
encompassed ∼14% of the de novo rearrangements, a
number higher than that shown in a previously pub-
lished study (Huret et al. 1988). This is yet another ex-
ample of how use of a combination of high-quality chro-
mosome analysis and FISH can lead to the detection of
an increased number of rearrangements and can improve
the delineation of these abnormalities. Although there
have been 1100 cases of 9p deletions reported, previous
cytogenetic studies have been limited in scope. Only 2
of the 80 cases (41 of which were de novo) reviewed by
Huret et al. (1988) were due to de novo rearrangements.
Our findings suggest that these rearrangements may oc-
cur at a frequency higher than previously reported and
that the use of high-quality cytogenetic analysis with
molecular cytogenetics is essential for the proper analysis
of this group of abnormalities.
Breakpoint Analysis
Although 1100 cases of 9p deletions have been re-
ported (Huret et al. 1988; Burton et al. 1989; Taylor et
al. 1991; Bennett et al. 1993; Teebi et al. 1993; Shashi
et al. 1994; Wagstaff and Hemann 1995), the vast ma-
jority have been analyzed with only standard banding,
yielding breakpoints in the range from 9p21 to 9p24.
In our study, even with high-resolution chromosome
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analysis, it was difficult to differentiate the majority of
the breakpoints. This is not surprising and is substan-
tiated by numerous reports in the literature that have
indicated the lack of a consensus breakpoint associated
with the 9p-deletion syndrome.
Our study was undertaken to determine a consensus
breakpoint; however, when a series of YACs and STSs
were used,10 different breakpoints were identified (fig.
1). Eight (33%) of the breaks, the largest breakpoint
group identified, were localized to a small region in 9p22
(group 1). Twelve other breaks (50%) were localized to
a more proximal 2-Mb region, in 9p22, which included
seven different breakpoints (groups 3–9; see fig. 1).
These heterogeneous findings are surprising in view of
the reports of site-specific breakpoints in several other
deletion syndromes. A large number of deletion syn-
dromes, especially contiguous-gene syndromes, have
now been studied with detailed molecular techniques to
elucidate breakpoints. Specific breakpoint sites have
been found in 184% of the deletions seen in Smith-
Magenis syndrome, and a novel junction fragment has
been identified in 29 unrelated patients with Smith-Ma-
genis syndrome (Juyal et al. 1996; Chen et al. 1997).
Similar findings have been reported for Prader-Willi and
Angelman syndromes, for DiGeorge syndrome, and for
the 17p duplication and 17p deletion associated, re-
spectively, with Charcot-Marie-Tooth (CMT) syndrome
and hereditary neuropathy with liability to pressure pal-
sies (HNPP) (Desmaze et al. 1993; Christian et al. 1995;
Lupski et al. 1996). In all of these syndromes, deletions
have been seen to occur at the same breakpoints, in the
majority of the reported cases (Desmaze et al. 1993;
Lindsay et al. 1995). Repetitive sequences have been
implicated in the formation of the deletion in Prader-
Willi and Angelman syndromes, and both repetitive se-
quences and the presence of a mariner transposon-like
element have been implicated in the formation of both
the deletion in HNPP and the duplication in CMT
(Amos-Landgraf et al. 1994; Reiter et al. 1996; Kiyo-
sawa and Chance 1996). In contrast to these studies,
analysis of X isochromosomes and ring X chromosomes
indicates not one site-specific break but, rather, a series
of breaks within a small region (!5 Mb) (Wolff et al.
1994, 1996), similar to what has been seen in the present
study. Additionally, studies of the formation of dicentric
chromosome 15, inv dup(15), have shown several dif-
ferent areas of breakage (Leana-Cox et al. 1994).
It is not clear whether the deletions examined in the
present study are interstitial or terminal. The cytological
studies do not provide any obvious evidence that these
are interstitial deletions; however, molecular methods
must be used to detect and confirm cryptic rearrange-
ments. Results of preliminary FISH experiments with
YACs from 9p24 have also been compatible with a ter-
minal versus an interstitial deletion (data not shown).
9p-Deletion Critical Region
In recent years, many different deletion syndromes
have been examined to determine the minimal segment
that is required to be deleted to produce a consensus
phenotype. This has been most extensively studied in
several contiguous-gene-deletion syndromes with micro-
deletions, such as Miller-Dieker syndrome, Smith-Ma-
genis syndrome, Prader-Willi syndrome, and Angelman
syndrome (Dobyns et al. 1993; Nicholls 1993; Buiting
et al. 1995; Pilz et al. 1995; Juyal et al. 1996). In all of
these syndromes, although studies are still ongoing,
small regions have been implicated by molecular studies
(Pilz et al. 1995; Juyal et al. 1996). This is also true for
some of the larger-deletion syndromes, such as Wolf-
Hirschhorn syndrome, cri-du-chat syndrome, Jacobsen
syndrome, and 13q-deletion syndrome (Brown et al.
1993, 1995; Church et al. 1995; Estabrooks et al. 1995;
Penny et al. 1995). Our studies have reduced the size of
the critical region initially reported by Wagstaff and He-
mann (1995) (i.e., from D9S286 to D9S162) and suggest
that a critical region in the 9p-deletion syndrome can be
assigned to an ∼4–6-Mb region from D9S286 to
D9S285. All of the patients with a break centromeric to
D9S274 (i.e., groups 1–10; see fig. 1) demonstrate the
consensus 9p-deletion phenotype.
Parental Origin of the Deletion
Our studies have confirmed that the deletion/rear-
rangements in this syndrome can be of either maternal
or paternal origin (Micale et al. 1995). This suggests
that no known imprinted genes are involved in the path-
ogenesis of this syndrome, such as in Prader-Willi syn-
drome and Angelman syndrome (Nicholls 1993). Also,
it agrees with previous studies indicating that no known
imprinted genes are on human chromosome 9 (Ledbetter
and Engel 1995).
Closer examination of these data does, however, re-
veal some intriguing points (table 1). When only dele-
tions (not including either familial or de novo unbal-
anced rearrangements, since they may have indifferent
underlying mechanisms) are viewed on the basis of the
breakpoint group, the following results were seen: (1)
four of five deletions in group 1 were paternal in origin;
(2) three of the four deletions in groups 5 and 6 were
paternal in origin; and (3) the deletions in group 8 were
all maternal. Therefore, although paternal and maternal
origin may be equally common overall, it is possible that
the location of the breaks is correlated with parental
origin.
In this study we have examined the origins and break-
age in the 9p-deletion syndrome. Although these breaks
have been found to occur in both maternal and paternal
meiosis, no site-specific location of the breaks has been
identified; rather, the breakage appears to be very het-
1394 Am. J. Hum. Genet. 65:1387–1395, 1999
erogeneous, with 10 different breakpoint regions having
been identified. Additional work will identify whether
these breaks involve repetitive sequences of DNA, will
address whether the breaks can be further subdivided as
more genomic resources become available, and will al-
low more-complete phenotype-genotype correlations.
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